Huayi Taikang is an innovative drug developer and a comprehensive pharmaceutical enterprise integrating the research and development, production, export and sales of high-end oral solid preparations. customized service. Recently, Huayi Taikang completed a B+ round of financing of nearly 100 million yuan, led by industrial investor Haixiang Pharmaceutical. This round of financing will be used for the company’s continuous research and development of high-end formulations and the construction of a new cGMP workshop.
This article is reproduced from: https://www.itjuzi.com/investevent/13310261
This site is for inclusion only, and the copyright belongs to the original author.